Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test

被引:12
作者
Bonfield, TL
John, N
Barna, BP
Kavuru, MS
Thomassen, MJ
Yen-Lieberman, B
机构
[1] Cleveland Clin Fdn, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Clin Pathol, Cleveland, OH 44195 USA
[3] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA
关键词
D O I
10.1128/CDLI.12.7.821-824.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pulmonary alveolar proteinosis (PAP) is characterized by the accumulation of lipoproteinaceous material within the lung alveoli. Recent studies indicate that PAP is an autoimmune disease characterized by a neutralizing anti-granulocyte macrophage colony stimulating factor (GM-CSF) antibody. At present the only definitive diagnostic test for PAP is open lung biopsy. We have previously published that anti-GM-CSF is diagnostic for PAP and correlates with disease pathogenesis using a traditional serial anti-GM-CSF antibody titer format (T. L. Bonfield, M. S. Kavuru, and M. J. Thomassen, Clin. Immunol. 105:342-350, 2002). Titer analysis is a semiquantitative method, and often subtle changes in antibody titer are not detectable. In this report we present data to support anti-GM-CSF detection by a quantitative highly sensitive multiplexed particle-based assay which has the potential to be a clinical diagnostic test.
引用
收藏
页码:821 / 824
页数:4
相关论文
共 20 条
[1]   Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins [J].
Biagini, RE ;
Sammons, DL ;
Smith, JP ;
MacKenzie, BA ;
Striley, CAF ;
Semenova, V ;
Steward-Clark, E ;
Stamey, K ;
Freeman, AE ;
Quinn, CP ;
Snawder, JE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) :50-55
[2]   Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis [J].
Bonfield, TL ;
Kavuru, MS ;
Thomassen, MJ .
CLINICAL IMMUNOLOGY, 2002, 105 (03) :342-350
[3]   Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis [J].
Bonfield, TL ;
Russell, D ;
Burgess, S ;
Malur, A ;
Kavuru, MS ;
Thomassen, MJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (04) :481-486
[4]   Report from a workshop on multianalyte microsphere assays [J].
Earley, MC ;
Vogt, RF ;
Shapiro, HM ;
Mandy, FF ;
Kellar, KL ;
Bellisario, R ;
Pass, KA ;
Marti, GE ;
Stewart, CC ;
Hannon, WH .
CYTOMETRY, 2002, 50 (05) :239-242
[5]  
Gilburd Boris, 2004, Clin Dev Immunol, V11, P53, DOI 10.1080/10446670410001670490
[6]   Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis [J].
Kavuru, MS ;
Sullivan, EJ ;
Piccin, R ;
Thomassen, MJ ;
Stoller, JK .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1143-1148
[7]   Therapeutic whole lung lavage - A stop-gap therapy for alveolar proteinosis [J].
Kavuru, MS ;
Popovich, M .
CHEST, 2002, 122 (04) :1123-1124
[8]   Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers [J].
Khan, SS ;
Smith, MS ;
Reda, D ;
Suffredini, AF ;
McCoy, JP .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 61B (01) :35-39
[9]   Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor [J].
Kitamura, T ;
Tanaka, N ;
Watanabe, J ;
Uchida, K ;
Kanegasaki, S ;
Yamada, Y ;
Nakata, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :875-880
[10]   Serological diagnosis of idiopathic pulmonary alveolar proteinosis [J].
Kitamura, T ;
Uchida, K ;
Tanaka, N ;
Tsuchiya, T ;
Watanabe, J ;
Yamada, Y ;
Hanaoka, K ;
Seymour, JF ;
Schoch, OD ;
Doyle, I ;
Inoue, Y ;
Sakatani, M ;
Kudoh, S ;
Azuma, A ;
Nukiwa, T ;
Tomita, T ;
Katagiri, M ;
Fujita, A ;
Kurashima, A ;
Kanegasaki, S ;
Nakata, K .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :658-662